Investigating the ability of statin-mediated ERK5 activation to protect cardiac microvascular endothelial cells and cardiomyocytes against the adverse effects of doxorubicin.

University of Liverpool 2026 Open access

Read full text

Authors: Shrouq Almaghrabi

DOI: 10.17638/03193630

Cited by: 0

Fields of Study & Subjects

Chemotherapy-induced cardiotoxicity and mitigation Cancer Lipids and Metabolism Cardiac Ischemia and Reperfusion